State of Alaska Department of Revenue decreased its position in Addus HomeCare Co. (NASDAQ:ADUS – Free Report) by 3.5% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 10,645 shares of the company’s stock after selling 386 shares during the quarter. State of Alaska Department of Revenue owned approximately 0.07% of Addus HomeCare worth $986,000 as of its most recent SEC filing.
Other institutional investors also recently modified their holdings of the company. BlackRock Inc. increased its position in Addus HomeCare by 1.4% during the first quarter. BlackRock Inc. now owns 2,664,889 shares of the company’s stock worth $248,608,000 after acquiring an additional 37,830 shares during the period. Vanguard Group Inc. increased its position in Addus HomeCare by 1.1% during the third quarter. Vanguard Group Inc. now owns 1,115,872 shares of the company’s stock worth $106,276,000 after acquiring an additional 12,363 shares during the period. Morgan Stanley increased its position in Addus HomeCare by 744.6% during the fourth quarter. Morgan Stanley now owns 907,193 shares of the company’s stock worth $90,257,000 after acquiring an additional 799,785 shares during the period. Eaton Vance Management increased its position in Addus HomeCare by 20.9% during the first quarter. Eaton Vance Management now owns 754,080 shares of the company’s stock worth $70,348,000 after acquiring an additional 130,469 shares during the period. Finally, Wellington Management Group LLP boosted its stake in Addus HomeCare by 4.0% during the first quarter. Wellington Management Group LLP now owns 677,183 shares of the company’s stock worth $72,296,000 after buying an additional 26,010 shares in the last quarter. Institutional investors own 95.26% of the company’s stock.
Addus HomeCare Stock Up 2.0 %
Shares of NASDAQ ADUS opened at $81.85 on Tuesday. The firm’s 50-day simple moving average is $87.09 and its 200 day simple moving average is $91.79. The company has a market cap of $1.33 billion, a price-to-earnings ratio of 24.71, a price-to-earnings-growth ratio of 1.76 and a beta of 0.86. The company has a quick ratio of 1.55, a current ratio of 1.55 and a debt-to-equity ratio of 0.12. Addus HomeCare Co. has a 12-month low of $77.30 and a 12-month high of $114.99.
Analyst Upgrades and Downgrades
ADUS has been the topic of a number of recent research reports. Raymond James lifted their price target on shares of Addus HomeCare from $100.00 to $105.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 2nd. Oppenheimer reiterated an “outperform” rating and set a $118.00 price target on shares of Addus HomeCare in a research note on Wednesday, August 2nd. StockNews.com upgraded shares of Addus HomeCare from a “buy” rating to a “strong-buy” rating in a research note on Saturday, October 7th. TheStreet downgraded shares of Addus HomeCare from a “b-” rating to a “c+” rating in a research note on Wednesday, September 13th. Finally, Stephens boosted their target price on shares of Addus HomeCare from $100.00 to $110.00 and gave the company an “overweight” rating in a research note on Wednesday, August 2nd. Four investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus price target of $110.50.
Get Our Latest Report on Addus HomeCare
Insider Buying and Selling
In related news, CEO R Dirk Allison sold 24,922 shares of the company’s stock in a transaction dated Thursday, August 3rd. The shares were sold at an average price of $94.39, for a total transaction of $2,352,387.58. Following the transaction, the chief executive officer now owns 52,850 shares in the company, valued at approximately $4,988,511.50. The sale was disclosed in a filing with the SEC, which can be accessed through this link. In other Addus HomeCare news, CEO R Dirk Allison sold 24,922 shares of the business’s stock in a transaction dated Thursday, August 3rd. The stock was sold at an average price of $94.39, for a total transaction of $2,352,387.58. Following the completion of the sale, the chief executive officer now directly owns 52,850 shares of the company’s stock, valued at approximately $4,988,511.50. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Brian Poff sold 4,140 shares of the business’s stock in a transaction dated Friday, August 4th. The stock was sold at an average price of $93.55, for a total value of $387,297.00. Following the sale, the chief financial officer now directly owns 22,217 shares of the company’s stock, valued at $2,078,400.35. The disclosure for this sale can be found here. Insiders have sold a total of 34,812 shares of company stock worth $3,279,405 in the last 90 days. Corporate insiders own 4.40% of the company’s stock.
About Addus HomeCare
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates through three segments: Personal Care, Hospice, and Home Health.
Featured Stories
- Five stocks we like better than Addus HomeCare
- How to Use the MarketBeat Dividend Calculator
- Warren Buffett Stocks: What’s in Warren Buffett’s Portfolio?
- What is a Secondary Public Offering? What Investors Need to Know
- Snack Maker Mondelez Int’l Is Down but Not Out
- Upcoming IPO Stock Lockup Period, Explained
- Costco, Dollar General, Target Up As Market Turns Defensive
Want to see what other hedge funds are holding ADUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Addus HomeCare Co. (NASDAQ:ADUS – Free Report).
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.
